336 related articles for article (PubMed ID: 20540111)
21. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
[TBL] [Abstract][Full Text] [Related]
22. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
[TBL] [Abstract][Full Text] [Related]
23. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
24. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
25. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.
Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N
J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575
[TBL] [Abstract][Full Text] [Related]
26. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
[TBL] [Abstract][Full Text] [Related]
27. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
28. Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells.
Kaminitz A; Mizrahi K; Yaniv I; Stein J; Askenasy N
J Autoimmun; 2010 Sep; 35(2):145-52. PubMed ID: 20638242
[TBL] [Abstract][Full Text] [Related]
29. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
Oling V; Marttila J; Ilonen J; Kwok WW; Nepom G; Knip M; Simell O; Reijonen H
J Autoimmun; 2005 Nov; 25(3):235-43. PubMed ID: 16263242
[TBL] [Abstract][Full Text] [Related]
30. T cells to a dominant epitope of GAD65 express a public CDR3 motif.
Quinn A; McInerney M; Huffman D; McInerney B; Mayo S; Haskins K; Sercarz E
Int Immunol; 2006 Jun; 18(6):967-79. PubMed ID: 16641112
[TBL] [Abstract][Full Text] [Related]
31. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
Tisch R; Wang B; Serreze DV
J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
[TBL] [Abstract][Full Text] [Related]
32. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
[TBL] [Abstract][Full Text] [Related]
33. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
[TBL] [Abstract][Full Text] [Related]
34. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L
Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
[TBL] [Abstract][Full Text] [Related]
35. Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice.
Balasa B; Lee J; Sarvetnick N
Cell Immunol; 1999 May; 193(2):170-8. PubMed ID: 10222059
[TBL] [Abstract][Full Text] [Related]
36. Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: role of T regulatory cells.
Soukhareva N; Jiang Y; Scott DW
Cell Immunol; 2006 Mar; 240(1):41-6. PubMed ID: 16860296
[TBL] [Abstract][Full Text] [Related]
37. Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes.
Oling V; Reijonen H; Simell O; Knip M; Ilonen J
Cell Immunol; 2012; 273(2):133-9. PubMed ID: 22270037
[TBL] [Abstract][Full Text] [Related]
38. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.
Quinn A; McInerney B; Reich EP; Kim O; Jensen KP; Sercarz EE
J Immunol; 2001 Mar; 166(5):2982-91. PubMed ID: 11207247
[TBL] [Abstract][Full Text] [Related]
39. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
[TBL] [Abstract][Full Text] [Related]
40. Recognition of Ii-Key/MHC class II epitope hybrids derived from proinsulin and GAD peptides by T cells in type 1 diabetes.
Vadacca M; Valorani MG; von Hofe E; Kallinteris NL; Buzzetti R; Pozzilli P
Horm Metab Res; 2011 Jun; 43(7):483-8. PubMed ID: 21512962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]